Aarey Drugs & Pharmaceuticals Share Price
95.00+0.56 (+0.59%)
+36.46% past 1 Year
Aarey Drugs & Pharmaceuticals Ltd.is engaged in the manufacturing of drugs and intermediates such as metronidazole metronidazole benzoate methyl and nitro imidazole. The Therapeutic targets of the company's products are
Corporate filings & documents
Announcements
As per the attachment
2 weeks agoAs per the attachment
2 weeks agoAs per Attachment
2 weeks agoAs per Attachment
2 weeks agoOutcome of Board Meeting held on friday 14th August 2026
2 weeks agoOutcome of Board Meeting held on friday 14th August 2026
2 weeks agoAarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve This is to intimate that the meeting of the Board of Directors of the Company is scheduled to be held on Friday14th August 2026 to transact the following business:1. To consider and approve the Unaudited Financial Result along with Limited review Report for the quarterended 30th June 2026.2. Any other matter with consent of the Chairman.
3 weeks agoAarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve This is to intimate that the meeting of the Board of Directors of the Company is scheduled to be held on Friday14th August 2026 to transact the following business:1. To consider and approve the Unaudited Financial Result along with Limited review Report for the quarterended 30th June 2026.2. Any other matter with consent of the Chairman.
3 weeks agoAllotment of Equity Shares Pursuant to Conversion of Warrants
4 weeks agoAllotment of Equity Shares Pursuant to Conversion of Warrants
4 weeks agoCompliance Certificate under Reg 74(5) of Sebi(DP) Regulation 2018
1 month agoCompliance Certificate under Reg 74(5) of Sebi(DP) Regulation 2018
1 month agoIntimation for closure of trading window
2 months agoIntimation for closure of trading window
2 months agoAs per Attachment
3 months agoAs per attachment
3 months agoAs per attachment
3 months agoas per attachment
3 months agoas per attachment
3 months agoAs per Attachment
3 months agoAs per Attachment
3 months agoOutcome of Board Meeting held on Saturday 30th May 2026
3 months agoOutcome of Board Meeting held on Saturday 30th May 2026
3 months agoAarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve intimation regarding postponement and re-schedule of Board Meeting which was scheduled to be held on Friday 29th May 2026 is postponed and rescheduled on Saturday 30th May 2026
3 months agoAarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve intimation regarding postponement and re-schedule of Board Meeting which was scheduled to be held on Friday 29th May 2026 is postponed and rescheduled on Saturday 30th May 2026
3 months agoAarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 This is to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday 29th May 2026 inter alia for the following:1. To consider and approve the Audited Financial Results along with the Auditors Report thereon of the Company for the quarter and financial year ended March 31 2026.2. To Consider any other matter with the permission of chair.
3 months agoAarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 This is to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday 29th May 2026 inter alia for the following:1. To consider and approve the Audited Financial Results along with the Auditors Report thereon of the Company for the quarter and financial year ended March 31 2026.2. To Consider any other matter with the permission of chair.
3 months agoCertificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations 2018
4 months agoCertificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations 2018
4 months agoIntimation for closure of trading window
5 months agoIntimation for closure of trading window
5 months agoNewspaper Publication of the Unaudited Financial Results
6 months agoBoard Comments on the fine levied by the Exchange
6 months agoApproval of Unaudited Financial Results for the quarter ended 31st December 2025
6 months agoThis is to inform you that the Board of Directors of the Company at its Meeting held today i.e. 11th February 2026 have passed the following resolution.1. The Board of Directors of the Company has considered and approved the Unaudited Financial Results for the quarter ended 31st December 2025 along with the Limited Review Report Report MD/CFO certification.*Company segment is single
6 months agoAarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve This is to intimate that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday11th February 2026 to transact the following business: 1. To consider and approve the Unaudited Financial Result along with Limited review Report for the quarter ended 31st December 2025.
7 months agoCertificate under reg 74(5) of SEBI (Depositories and Participants) Regulations 2018
7 months agoIntimation for Closure of Trading Window
8 months agoNewspaper Publication of the Unaudited Financial Results
9 months agoApproval of Unaudited Financial results for the quarter & half year ended on 30th Sept 2025
9 months agoOutcome of Board meeting for approval of Unaudited Financial Results for the quarter and half year ended 30th September 2025
9 months agoAarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve This is to intimate that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday 13th November 2025 to transact the following business:1. To consider and approve the Unaudited Financial Result along with Limited review Report for the quarter and half year ended 30th September 2025.2. Any other matter with consent of the Chairman.
9 months agoCertificate under regulation 74(5) of SEBI (Depository and Participants) Regulations 2018 for the quarter and half year ended 30th September 2025
11 months agoDisclosure on Voting Results along with Consolidated Scrutinizers Report of 35th Annual General Meeting of the Company
11 months agoClosure of Trading Window for the Quarter and half year ended 30 September 2025
11 months agoAGM Proceedings of the 35th Annual General Meeting of the Company
11 months agoCorrigendum to the integrated Annual Report for FY 2024-25
11 months agoNewspaper Publication
11 months agoNotice and Integrated Annual Report for 35th Annual General Meeting of Company as required underRegulation 34(1)
12 months agoNotice of 35th Annual General Meeting of the company for the financial year 2024-25
12 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
E 34 M I D C Tarapur Boisar Thane Maharashtra PIN: 401506 Tel No: 02525 271049 Fax No: NULL Email: [email protected] Internet: www.aareydrugs.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Mihir R Ghatalia, Chairman & Managing Director
Mihir R Ghatalia, Chairman & Managing Director
Nimit R Ghatalia, Whole Time Director
Chetan Kiritbhai Mehta, Non Executive Independent Director
Lalit R Tulsiani, Non Executive Independent Director
Anil Mandal, Non Executive Independent Director
Bina Ghatalia, Non Executive Woman Director
Kailash Chand Jethlia, Company Secretary & Compliance Officer
Details
BSE 524412
NSE AAREYDRUGS
ISIN INE198H01019